Biotech Values

[alertmeipp]

$ENTA - target price of $15, so we are talking about 40% upside? And that's not outperform LOL. Analyst target price is just for fun.

And $15 is pretty much the net cash value, so he is not saying the current trend is reducing ED-235 partnerability. He is saying ENTA's royalty steam, pipeline and option value on $PFE lawsuit worth ZERO.